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Background: Evidence is needed on the effectiveness of wearing face masks in the
community to prevent SARS-CoV-2 transmission.
Methods: Systematic review and meta-analysis to investigate the efficacy and
effectiveness of face mask use in a community setting and to predict the effectiveness of
wearing a mask. We searched MEDLINE, EMBASE, SCISEARCH, The Cochrane Library,
and pre-prints from inception to 22 April 2020 without restriction by language. We rated
the certainty of evidence according to Cochrane and GRADE approach.
Findings: Our search identified 35 studies, including three randomized controlled
trials (RCTs) (4,017 patients), 10 comparative studies (18,984 patients), 13 predictive
models, nine laboratory experimental studies. For reducing infection rates, the estimates
of cluster-RCTs were in favor of wearing face masks vs. no mask, but not at statistically
significant levels (adjusted OR 0.90, 95% CI 0.78–1.05). Similar findings were reported in
observational studies. Mathematical models indicated an important decrease in mortality
when the population mask coverage is near-universal, regardless of mask efficacy. In the
best-case scenario, when the mask efficacy is at 95%, the R0 can fall to 0.99 from an
initial value of 16.90. Levels of mask filtration efficiency were heterogeneous, depending
on the materials used (surgical mask: 45–97%). One laboratory study suggested a viral
load reduction of 0.25 (95% CI 0.09–0.67) in favor of mask vs. no mask.
Interpretation: The findings of this systematic review and meta-analysis support the
use of face masks in a community setting. Robust randomized trials on face mask
effectiveness are needed to inform evidence-based policies.
PROSPERO registration: CRD42020184963.
Keywords: pandemics, face mask, prevention and control [MeSH], SARS—CoV−2, COVID−19, disease outbreaks,
community, systematic review
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INTRODUCTION
Coronavirus disease 2019 (COVID-19) is a new, rapidly
emerging infectious disease caused by a novel coronavirus,
SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus-
2), which is primarily transmitted via droplets during close
unprotected contact with an infector and fomites (1, 2). The
virus is genetically similar to the coronaviruses that caused
Severe Acute Respiratory Syndrome (SARS) and the Middle
East respiratory syndrome (MERS), but SARS-CoV-2 appears
to have greater transmissibility and lower pathogenicity than
the aforementioned viruses (3). Preliminary estimates of the
basic reproduction number (R0) of SARS-CoV-2, as a metric for
transmissibility, range from 2.8 to 5.5, in the absence of intense
quarantine and social distancing measures (4). COVID-19 has
a higher hospitalization and mortality rate than influenza (5–7)
and is spreading in an immune naive population (8). As of 30
November 2020, 61.8 million cases have been infected around
the world counting over 1.4 million deaths (9). Moreover, there
is increasing evidence that people with mild or no symptoms at
the pre-symptomatic and early stages of infection can contribute
to the spread of COVID-19 (10).
Since there is no effective treatment nor any vaccine for
COVID-19, strategies for reducing the burden of the pandemic
are focused on non-pharmaceutical interventions for reducing
the spread of the infection, such as social-distancing measures,
contact-tracing, quarantine, isolation, and the use of face masks
in public (11). Public health policies promoting the use face
masks in the community, i.e., in public places, can therefore
have an important role in controlling the spread of the SARS-
CoV-2 virus and for COVID-19 lockdown exit strategies (12).
The published literature on the efficacy, effectiveness and
acceptability of different types of face mask in preventing
respiratory infections during epidemics is scarce and conflicting.
However, face mask use is increasingly recommended and
the potential of this intervention is not well-understood (13).
National and international health organizations have adopted
divergent policies on the subject. Recently, the CDC (Centers
for Disease Control and Prevention) and the ECDC (European
Center for Disease Prevention and Control) have advocated the
use in public places of non-medical face mask (e.g., cloth mask)
as a measure for the prevention and/or containment of SARS-
CoV-2 infection (10, 14). In areas of significant community-
based transmission, where it is difficult to maintain 6-feet
Abbreviations: aOR, Adjusted Odds Ratio; CI, Confidence Interval; COVID-19,
Coronavirus disease 2019; CDC, Centers for Disease Control and Prevention;
CHARMS, Checklist for critical Appraisal and data extraction for systematic
Reviews of prediction Modeling Studies; ECDC, European Center for Disease
Prevention and Control; GRADE, Grades of Recommendation, Assessment,
Development and Evaluation; MERS, Middle East respiratory syndrome; MOOSE,
Guidelines for Meta-analysis and Systematic reviews of observational studies;
NOS, Newcastle Ottawa scale for non-randomized studies; PRISMA, Preferred
reporting items for systematic reviews and meta-analyses; PROBAST, Prediction
model Risk Of Bias Assessment Tool; RCT, Randomized Controleld Trials; RR,
Risk Ratio; QUADRIAC, QUAntitative-Deterministic models Risk of Infeasibility
Assessment Checklist; SARS, severe acute respiratory syndrome; SARS-CoV-2,
severe acute respiratory syndrome coronavirus-2; SR, Systematic Reviews; SOF,
Summary of Findings; WHO, World Health Organization.
social distancing (e.g., grocery stores and pharmacies), CDC
recommends wearing cloth face coverings. CDC is additionally
advising the use of simple cloth face coverings to slow the spread
of the virus and help reduce the transmission of the virus from
people who may be infectious without knowing it (14). The
World Health Organization (WHO) conditionally recommends
face mask use in the community for asymptomatic individuals in
severe epidemics or pandemics in order to reduce transmission
in the community (15) but it does not recognize its effectiveness
in preventing infection (1).
Medical and non-medical face masks are used extensively
by the general population in Asian countries, such as China,
Singapore, South Korea, and Japan. Face mask wearing practice
has been adopted since the 2003 SARS epidemic in addition
to many other response measures and practices, including
respiratory etiquette and hand hygiene (10). In Europe, as of 1
April 2020, Lithuania, Austria, Czechia, Slovakia, and Bulgaria
recommend the use of face masks for persons going out in
public (10).
Previous systematic reviews on the effectiveness of face
mask use mainly focused on healthcare and household setting
including only randomized controlled trials (RCTs) with most of
them of low quality (16–19).We therefore conducted a systematic
review of the existing scientific literature, with randomized trials
and observational studies, including modeling and experimental
studies, on the effectiveness and efficacy of wearing face masks
in the community for reducing the spread of COVID-19 in
non-healthcare and non-household setting.
AIM
The aims of this systematic review (SR) were:
(i) to assess the efficacy and effectiveness of using masks in
a community setting to reduce the spread of COVID-19
or other similar pandemic (20, 21); and in particular, to
evaluate the effects of using vs. not using masks onmortality,
infection rate and basic reproduction number (R0).
(ii) to investigate the effect of different filtering capacity of
masks used in community settings on the diffusion of the
SARS- CoV2.
METHODS
The systematic review protocol was registered with the
International Prospective Register of Systematic Reviews
database (PROSPERO identifier: CRD42020184963). The study
protocol and preliminary results are publicly available on https://
osf.io/uvjgq. We conducted the systematic review following
the preferred reporting items for systematic reviews and meta-
analyses, the PRISMA statement (22), and theMOOSE guidelines
for conducting meta-analysis of observational studies (23).
Search Strategy
We searched for studies on the electronic databases MEDLINE,
EMBASE, SCISEARCH, and The Cochrane Library from
inception to April 22, 2020 using index terms related to face
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mask use in reducing spread of pandemic infection viruses.
Gray literature was interrogated in MedRxiv, Rxiv, and bioRxiv
databases. We hand searched the reference lists of the included
papers. We also incorporated the studies included in any
identified relevant systematic reviews. The full search strategy is
reported in Supplementary Appendix 1.
Eligibility Criteria
According to our PICOS questions (24), the following eligibility
criteria without limit of study design were searched:
i) Population: general population exposed to SARS-COV-2
infection or other similar virus (20, 21);
ii) Intervention and comparators: any type ofmask such as non-
medical face mask (i.e., cloth, gauze, tissue), medical face
mask (i.e., surgical) and N95 respirators vs. no mask;
iii) Outcomes: mortality, respiratory infection rate (number of
events) and the R0 of viral respiratory infections; filtering
capacity of masks and viral load reduction.
iv) Setting: we defined “community-based setting” people of a
group or unit that collectively sharing interests in the society
for real life situations (e.g., schools, work, open spaces).
Studies assessing the intervention in particular closed cluster
setting exposed to higher risk of infection such as healthcare
workers or households were excluded.
Study Selection
Two reviewers independently screened the articles based on the
titles, abstracts and full texts. The same two review authors
independently retrieved and assessed full reports for potentially
relevant studies for inclusion and exclusion according to the
above criteria using a predefined electronic spreadsheet. In
case of disagreement, consensus was achieved by involving a
third independent review author. The reviewers’ decisions and
reasons for exclusion were recorded using appropriate reference
management software such as EndNote. The study selection
process was reported using the flow diagram of the Preferred-
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) (22).
Data Extraction
Two reviewers independently extracted the study characteristic
(e.g., first author, publication year, country, type of virus detected,
study design, sample size, settings); for prognostic models, they
extracted key characteristics (e.g., factors/predictors, time span,
accuracy, and performance) and outcomes to be predicted.
Disagreements were solved by consensus. A detailed data
extraction form was developed prior to the systematic review
being performed. In addition, for prediction modeling studies,
the Checklist for critical Appraisal and data extraction for
systematic Reviews of prediction Modeling Studies (CHARMS)
was utilized (25).
Primary and Secondary Outcomes
The primary outcomes of this systematic review are the following:
- Mortality rate;
- Respiratory infection rate (measured as event frequency),
defined as fever ≥37.8◦C with at least 1 respiratory symptom
(sore throat, cough, sneezing, runny nose, nasal congestion,
headache), with or without laboratory confirmation.
- R0 of viral respiratory infections;
The secondary outcomes were filtering capacity of masks and
viral load reduction.
Data Analysis
We examined the efficacy and effectiveness of wearing a mask
and the models studies available in the literature by study
design, setting, and study outcome. The data are summarized
in both tabular and narrative formats. As the outcomes
were dichotomous, such as respiratory infection, they were
analyzed as pooled Risk Ratios (RRs), for unadjusted estimates.
Adjusted odds ratios from multivariable regression reported
in the studies were pooled as adjusted Odds Ratios (aORs).
These are summarized using random effects meta-analysis
using the DerSimonian and Laird random effects model (26),
with heterogeneity calculated from the Mantel-Haenszel model.
Due to the comprehensive definition of community-based
setting, when possible, studies were sub-grouped based on
study design and identified by appropriate setting to investigate
potentially different effects on primary outcomes. If enough
studies were present, we performed a sensitivity analysis of the
primary outcomes selecting routine conditions for community-
based setting excluding conditions at greater risk of gathering.
All summary measures were reported with an accompanying
95% confidence interval. Data analyses were performed using
RevMan Software.
Assessment of Study Quality
Two independent reviewers appraised the risk of bias. In case
of disagreement, a third reviewer was consulted. We used the
Cochrane risk of bias tool for randomized controlled trials
(27); the Newcastle Ottawa scale for non-randomized studies
(28). We planned to use the PROBAST (Prediction model Risk
Of Bias Assessment Tool) for Prediction Model Studies (29).
However, since we found only quantitative-deterministic models,
(statistical) bias was not a suitable measure of model goodness
and we analyzed the QUAntitative-Deterministic models Risk
of Infeasibility Assessment Checklist (QUADRIAC) according
to the appropriate guideline (30). We provided more details in
Supplementary Appendix 2.
GRADE—Quality of the Evidence
The Grades of Recommendation, Assessment, Development
and Evaluation (GRADE) framework for judging the quality
of evidence has been extended to prognosis factor research.
Evidence on prognostic models were evaluated by six factors
that may decrease quality: (1) phase of investigation; (2) study
limitations; (3) inconsistency; (4) indirectness; (5) imprecision;
and (6) publication bias; and by two factors that may increase
quality: (1) moderate or large effect size; and (2) exposure
response gradient (31). Two independent reviewers graded the
certainty of the evidence using the GRADE approach. Evidence
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FIGURE 1 | Flow diagram of study selection process.




A total of 684 records resulted from the searches in the
electronic databases (MEDLINE, EMBASE, SCISEARCH) and
from pre-prints; eleven additional records were identified
through citations. After removing duplicates and excluding
irrelevant records according to title, abstract and full text reading,
35 studies met our inclusion criteria for the final inclusion.
Figure 1 shows the flow diagram of the study selection process.
Description of the Included Studies
Table 1 reports characteristics of the included studies. Of the 35
included studies, three were cluster-RCTs (32, 33, 35), two cohort
studies (38, 41), four were case-control (47, 51, 62, 64), four cross-
sectional (34, 46, 49, 60), 13 were quantitative-deterministic
predictive models (11, 13, 36, 39, 40, 42, 43, 45, 55, 57–59, 63),
and nine were laboratory experimental studies (37, 44, 48, 50, 52–
54, 56, 61).
Of the 13 epidemiological studies (RCTs and observational
studies) included in the review, four were carried out in a
university (32, 33) or school setting (49, 60), one on an airplane
(64), six during mass gatherings (34, 35, 38, 41, 46, 47), and two
in non-specific community settings (51, 62).
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TABLE 1 | General characteristics of the included studies.






Aiello et al. (32) Cluster RCT USA University 930 H1N1 Influenza Yes
Aiello et al. (33) Cluster RCT USA University 816 H1N1 Influenza Yes
Al-Jasser et al. (34) Cohort Saudi Arabia Hajj pilgrimage 1,507 URTI No
Alfelali (35) Cluster RCT Saudi Arabia Hajj pilgrimage 7,687 vRTIs and CRI Unclear
Babak (36) SIR-based Israel Community 8 milions COVID-19 -





Balaban (38) Cohort (pre-post
survey)
Saudi Arabia Hajj pilgrimage 186 H1N1 Influenza No
Brienen et al. (39) SIR-based China Community Not reported Influenza -
Chen and Liao (40) SIR-based Taiwan Nursery and
primary school
494 Influenza -
Choudhry (41) Cohort Saudi Arabia Hajj pilgrimage 1,066 ARIs No
Cui et al. (42) SIR-based not reported Community 1 million Influenza H1N1 -
D’Orazio et al. (43) Agent-based Italy University
campus
5,000 COVID-19 -













Community not reported COVID-19 -
Deris (46) Cross-sectional Malaysia Hajj pilgrimage 387 ARIs No
Eikenberry et al. (13) SIR-based USA Community 1 million COVID-19 -
Emamian, (47) Nested case-control Iran Hajj pilgrimage 338 RTI (all types) Unclear




Kim (49) Cross-sectional South Korea Primary school 7,448 H1N1 Influenza Unclear
Lai et al. (50) Controlled
Comparison (2
manikins)
China Laboratory n.a. Airborne infections
Lau et al. (51) Case-control China Community 990 SARS Yes
Li et al. (52) In vivo experiments Hong Kong Laboratory 10 Viral respiratory infection -
Makison Booth et al.
(53)
Bench test
(Head of dummy test)





Milton et al. (54) In vivo experiment USA Laboratory 37 Seasonal influenza -
Mniszewski et al. (55) Agent-based USA Community 20 millions Influenza H1N1 -
Ngonghala (11) SIR-based USA Community 19.45 millions COVID-19 -
Rengasamy et al. (56) Bench test USA Laboratory n.a. Influenza -
Tian et al. (57) SIR-based China Community 159 COVID-19 -
Tracht et al. (58) SIR-based USA Community 1 million Influenza H1N1 -
Tracht et al. (59) SIR-based USA Community 302 millions Influenza H1N1 -
Uchida (60) Cross-sectional Japan Community 10,524 Influenza Unclear
van der Sande et al.
(61)
Bench test Netherlands Laboratory 61 Influenza -
Wu (62) Case-control China Community 375 SARS Unclear
Yan et al. (63) SIR-based USA Community Not reported Influenza -
Zhang et al. (64) Case-control USA-China Airplane 9 H1N1 Influenza No
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As far as the quantitative-deterministic models are concerned,
ten studies developed a SIR-based model (11, 13, 36, 39, 40,
42, 57–59, 63), two studies developed an agent-based model
(43, 55), and one study employed both (45). The whole
population was considered in all the studies but one, which
was restricted to nursery and primary school children (40).
Three out of the 13 modeling studies (40, 43, 45) considered
a closed environment; three models (45, 57, 63) contemplated
both inward and outward filtering capacity whereas the others
did not make such a distinction; furthermore, only two among
the reviewed studies have accounted for a proper usage of
facial masks (13, 57). It is worth mentioning that five out of
the 13 studies that have analyzed a quantitative-deterministic
model have also accounted for the intervention timing (11, 13,
42, 45, 59). Four studies across all the reviewed studies were
pre-prints (11, 24, 43, 57).
The laboratory experimental studies were highly
heterogeneous in terms of setting/participants: four bench
test (48, 53, 56, 61), two in vivo studies (52, 54), and three
controlled studies (37, 44, 50).
Supplementary Appendix 2 lists included and
excluded studies.
Risk of Bias of Epidemiologic Studies and
Unfeasibility of Deterministic Models
Focusing on randomized trials, we found high risk of
performance and detection bias. However, blinding of
participants was not possible due to the nature of the
interventions. The included trials were characterized by
an overall high quality. Among observational studies the
quality ranged from poor to fair for cohort and case-controls
studies, whereas it ranged from fair to good for cross-sectional
studies. Focusing on mathematical models, we evaluated the
unfeasibility of quantitative-deterministic models reporting
eight of 13 studies with medium overall risk of infeasibility
(two high and three low). Supplementary Appendix 3 lists
the risk of bias of epidemiologic studies and unfeasibility of
deterministic models.
Outcomes
Although no epidemiologic study on wearing face masks in
the community for reducing the spread of COVID-19 has been
published, a number of studies gave an indirect estimate of the
protective efficacy of masks for other viral respiratory infections
from agents similar to SARS-CoV2.
Mortality Rate
Deterministic Models
Four out of 13 quantitative-deterministic models reported
data on mortality (13, 36, 45, 59). Among them, only
one study (59) has explicitly provided quantitative data
in three scenarios based on different initial values of
R0; however, the time horizon was not specified. Three
studies (13, 36, 45) presented graphs depicting the
evolution over time of cumulative deaths. Overall the
studies point toward a reduction in mortality when the
TABLE 2 | Mortality rate in the quantitative-deterministic models.





















Extraction not possible—only graphs
De Kai
et al. (45)





2.2 Not reported 8 Near-universal Extraction not
possibile16 (% not
reported)
1.3 Not reported 8 Near-universal Extraction not
possibile16 (% not
reported)
population mask coverage is near-universal, regardless of
mask efficacy.
Table 2 describes the mortality in relation to the initial
R0, type of mask, mask filtration efficacy (%) and adherence
of population coverage (%). Summary of findings (SOF) are
displayed in Table 3.
Respiratory Infection Rate
RCT
The overall findings were similar between adjusted and
unadjusted estimates. With very low quality of the evidence
(Table 3), in the unadjusted data, three cluster-RCTs (32, 33, 35)
have reported a small non-significant reduction in the risk of
respiratory infections (Figure 2A, RR 0.97, 95% CI 0.72–1.31, I2
= 62%). The adjusted estimates of two, out of three, cluster-RCTs
(32, 33) confirmed the reduction with high consistency, even if
not at statistically significant levels (Figure 2B, aOR 0.90, 95% CI
0.78–1.05, I2 = 0%).
Observational Studies
In total, 10 observational studies were identified (34, 38, 41,
46, 47, 49, 51, 60, 62, 64), among which one study reported
adjusted data in relation to the outcome of interest (51). Thus,
the meta-analysis was reported only for unadjusted estimates.
The level of certainty of the evidence in all observational studies
was very low (Table 3), with no statistically significant effect; the
overall effect was very imprecise across all cross sectional studies
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TABLE 3 | Summary of findings.
Wearing a mask compared to no mask in a community setting
Patient or population: community
Intervention: mask wearing











Risk with no mask
wearing
Risk difference with mask
wearing
Mortality rate The general consensus points toward a reduction of deaths when













112 per 1,000 3 fewer cases per 1,000











172 per 1.000 17 fewer per 1.000
(45 fewer to 17 more)








405 per 1.000 166 fewer per 1.000
(267 fewer to 12 more)








584 per 1.000 263 fewer per 1.000
(520 fewer to 1,022 more)
Basic reproduction number
(R0) of viral respiratory
infection
In the worst-case scenario with a mask efficacy at 30% and a
population coverage at 20%, the R0 reduced from the initial value
of 2.0 to just 1.9 whereas in the best-case scenario when the
mask efficacy is at 95%, the R0 can fall to 0.99 from an initial value
of 16.90, even though no population neither coverage nor time
horizon are reported





High degree of variation of filtration efficiency depending on the
materials used. All types of masks might reduce aerosol exposure.
However, personal respirators were more efficient than surgical
masks, which were more efficient than home-made masks.








432 per 1.000 324 fewer per 1.000
(394 fewer to 143 fewer)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the
intervention (and its 95% CI). CI: Confidence interval; OR: Odds ratio
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility
that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
aHigh risk from multiple bias.
bNot COVID-19 population.
cThe line of “no difference” included important benefit and harms.
d I2 >75%.
eAscertainment of exposure.
fWide confidence intervals comprising important benefit and harm.
gAscertainment of exposure and assessment of the outcome.
h I2 >90%.
iExperimental study, high variability in type of masks equipment.
(four studies, OR 0.90, 95% CI 0.74–1.10, I2 = 74%) (Figure 3,
Comparison 1.3.1) (34, 46, 49, 60), case-control (four studies,
OR 0.59, 95% CI 0.34–1.03, I2 = 78%) (Figure 3, Comparison
1.3.2) (47, 51, 62, 64) and prospective cohort studies (two studies,
OR 0.55, 95% CI 0.11–2.75, I2 = 97%) (Figure 3, Comparison
1.3.3) (38, 41).
Since we found high heterogeneity, we performed sensitivity
analysis excluding aircraft and mass gathering studies to
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FIGURE 2 | (A) Unadjusted forest plot of respiratory infection rate and risk ratios in RCTs. (B) aORs forest plot of respiratory infection rate in RCTs.
determine the robustness of our original analyses and determine
whether special settings might have influenced the overall pooled
effect. Focusing on studies set in schools, universities and in the
general community, the evidence from cross-sectional studies
was not statistically significant (OR 0.74, 95% CI 0.43–1.26, I2 =
76%) (Supplementary Appendix 4, Supplementary Figure 2);
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FIGURE 3 | Forest plot of respiratory infection rate in observational studies.
whereas case-control studies (OR 0.46, 95% CI 0.34–0.62, I2
= 47%) (Supplementary Appendix 4, Supplementary Figure 2)
showed a statistically significant effect in favor of wearing
face masks vs. not wearing masks, with a more precise
overall estimate.
Deterministic Models
Ten out of 13 studies that deployed mathematical models
examined respiratory infection rates (11, 13, 36, 39, 40, 42,
43, 55, 57–59, 63). Across them, three studies (39, 43, 55)
reported such an outcome as a pure rate; two papers (42,
58) reported results about the respiratory infections rate as
the percentage of cumulative cases; one study (59) reported
the number of cumulative cases. The remaining studies did
not report intelligible results on respiratory infection rate.
Across the above-mentioned studies, the ones that reported
the use of N95 masks agree that when at least 50% of
the population is wearing a mask the respiratory infection
rate can be reduced by a percentage ranging from 80% up
to 99%.
The use of facial mask results in a reduction of the respiratory
infection rate that is at least of 2.0% in the worst case scenario
(58) and up to 99% in the best case scenarios (39, 58, 59). No
time-horizon is specified, though Supplementary Appendix 5,
Supplementary Table 9. The summary of Findings is displayed
in Table 3.
Basic Reproduction Number (R0) of Viral Respiratory
Infections
Deterministic Models
Seven out of 13 studies that deployed a mathematical model
investigated the R0 of viral respiratory infections (11, 39, 40,
42, 55, 57, 58). Across them, four papers reported explicitly the
results (40, 42, 51, 57), two papers only reported a graph (11, 39),
and the remaining one did not report accessible data (55). Across
these studies, the worst-case scenario was reported in the Brienen
et al. (39): with mask efficacy at 30% and a 20% population
coverage, the R0 reduced from the initial value of 2.0 to just 1.9.
On the other hand, the best-case scenario is reported in Chen
(40): with mask efficacy at 95%, the R0 can fall to 0.99 from
an initial value of 16.90; however, neither population coverage
nor time horizon are reported. Supplementary Appendix 5,
Supplementary Table 9 show the description of R0 of viral
respiratory infections across models. The summary of Findings
is displayed in Table 3.
Filtering Capacity of Masks
Among laboratory experimental studies, seven out of nine studies
reported the outcome as filtration rate or face mask protection,
including goodness-of-fit and filtration efficiency. Outcomes
varied according to the materials used.
In adults, generally filtration rate of household materials had
high degree of variation, ranging from 49 to 86% for 0.02µm
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exhaled particles (44) and from 3 to 60% for particles in the
relevant size range (56).
High degree of variation were also present in surgical masks.
One study (56) reported a filtration rate of surgical masks
comparable to that of masks made of household materials. Other
studies reported the best peformance for surgical masks, filtering
from 89% (44) to 95.5–97% (52) of small particles. Under a
pseudo-steady concentration environment, face mask protection
on average was found to be 45%, while under expiratory
emissions, protection varied from 33 to 100% for fully sealed face
mask (50).
Particularly, in pediatrics, penetration of neutralized
polydispersed sodium chloride aerosols varied significantly
between brands at the highest flow rates, from 15 to 50% (48).
All types of surgical masks provided a relatively stable
reduction of aerosol exposure over time, unaffected by duration
of wear or type of activity, but with a high degree of individual
variation with reductions ranging from 1.1- to 55-fold (average
6-fold), depending on the design of the mask (53). One study
compared all types of masks (N95 personal respirators, surgical
and home-made masks): surgical masks provided about twice as
much protection as home-made masks, with the difference being
slightly more marked among adults. N95 personal respirators
provided adults with about 50 times as much protection as home-
made masks, and 25 times as much protection as surgical masks
(61). The summary of Findings is displayed in Table 3.
Viral Load Reduction
Three experimental laboratory studies were included (37, 44, 54),
of which one study having three arms investigating surgical
masks, home-made masks (i.e., cotton mask) or no mask; two
studies focussed on the comparisons between surgical masks
vs. home-made masks or no mask (Supplementary Appendix 5,
Supplementary Table 10). According to our PICO, for the SOF
GRADE assessment only the comparison between surgical mask
vs. no mask reporting outcome data was considered (54). This
suggested a viral load reduction of 0.25 (0.09–0.67) in favor of
face mask use (risk difference: 324 fewer× 1,000) (Table 3).
DISCUSSION
We found very low-certainty evidence that wearing a face
mask is associated with a reduced risk of primary infection in
RCTs as well as in observational studies. However, the wide
confidence intervals affected the statistical significance of the
overall estimate. It was not possible to establish the certainty
of evidence about mortality, filtering capacity and R0 whereas
viral load was judged to be of very low quality. Our findings
indicate (i) a general consensus toward a reduction of deaths,
based on prediction modeling studies, when the population
mask coverage is near-universal, regardless of mask efficacy; (ii)
filtration efficiency depends on the face mask materials, with
studies showing high variability. It seems that all types of masks
reduce the viral exposure, even though the levels of protection, in
terms of reduction of susceptibility to infection in the wearer, are
probably lower for somematerials (i.e., clothmasks), to the extent
that they do not effectively protect against infectious aerosols.
Specifically, personal respirators were more efficient than surgical
masks, which were more efficient than home-made masks; (iii)
in the worst-case scenario with a mask efficacy at 30% and a
population coverage at 20%, the R0 reduced from the initial value
of 2.0 to just 1.9; whereas in the best-case scenario, when themask
efficacy is 95%, the R0 can fall to 0.99 from an initial value of
16.90, even though no population coverage nor time horizon is
reported; (iv) wearing vs. not wearing a mask is associated with
a reduction of viral load of RR 0.25 (95% CI 0.09–0.67, based on
one experimental laboratory study).
Overall, our findings support the recommendation on using
face masks in community settings in a pandemic era: home-made
masks, such as those made of teacloths, may confer a significant
degree of protection, albeit less strong than surgical masks or
N95 personal respirators. Mask efficacy at 95% (N95 personal
respirators) seems to be the best scenario, but it is difficult to
realize in terms of adherence and costs from a public health
perspective. A balanced compromise in the community could
be reached with high population coverage using surgical masks
(whose mask efficacy is >95%), which is easier to implement.
Comparing surgical masks to no mask has shown a viral load
reduction of a quarter (risk difference: 324 fewer × 1,000).
Surgical masks were more effective than homemade masks in
reducing the number of microorganisms expelled. However, high
levels of filtration efficiency have been found among surgical
and non-surgical masks, with evidence from all experimental
laboratory studies emphasizing the importance of high filtration
capacity irrespective of the materials used.
Our findings are in line with results from previous systematic
reviews, which however had different aims, population and
outcomes. For example, examining the infection rate in
pandemic influenza transmission Jefferson et al. (65) has shown
that wearing masks significantly decreased the spread of SARS
(OR = 0.32; 95% CI 0.25–0.40). Similar finding were found
in studies on respiratory virus infections including SARS,
H1N1, and COVID-19 in all subgroups, including non-health
care worker or non-household contacts (66). One review,
investigating the optimum use of different personal protective
equipment (face masks, respirators, and eye protection) in
community and health-care settings, reported a large reduction
in the risk of infection in favor of face mask use (OR 0.15; 95%
CI 0.07 to 0.34, RD −14.3%; −15.9 to −10.7; low certainty),
with stronger associations with N95 or similar respirators,
compared with disposable surgical masks or similar masks (67).
Anyway, this is the first systematic review and meta-analysis
comprising evidence based on different research methods and
study designs (e.g., modeling studies), to address the existing
uncertainty about the efficacy and effectiveness of wearing a
mask targeting the community setting for limiting the spread
of COVID-19.
A pragmatic ecologic study, involving 49 countries, used data
from the European Center for Disease Prevention and Control
(ECDC) and investigated the association between face mask use
in the community and cumulative number of cases of COVID-19
infection per million inhabitants, discovering that face mask use
was negatively associated with number of COVID-19 cases (coef.
−326; 95% CI−601 to−51, P = 0.021) (68).
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The results of this ecological study and of the individual-
level studies included in the review are in line with our findings,
supporting the use of face masks for reducing the transmission
and acquisition of respiratory viral infections in the community.
Strength and Limitations
Our review included experimental laboratory research and
mathematical modeling studies to complement observations
studies and trials, for obtaining a more complete picture
on mortality and viral load reduction, filtering capacity and
population coverage which are important factors influencing
the R0. We adopted full methodological rigor within a
much shorter time-frame compared to traditional reviews,
using enhanced processes. We also critically assessed the risk
of bias of included studies (randomized controlled studies
and observational studies) and infeasibility of mathematical
modeling studies.
Our systematic review has some limitations. Only a minority
of the included studies looked at COVID-19, mainly addressed by
modeling studies. We did not investigate the balance of pros and
cons of wearing a mask. On one hand, the use of face masks may
provide a false sense of security leading to suboptimal physical
distancing, poor respiratory etiquette and hand hygiene—and
possibly not staying at home when ill. There is a risk that
improper removal of the face mask, handling of a contaminated
face mask or an increased tendency to touch the face while
wearing a mask by healthy persons might actually increase the
risk of transmission (10). On the other hand, the fears related to
the paradoxical increase of the infectious risk for their improper
use are entirely theoretical, based on preconception without
real foundation. Education campaigns should be encouraged for
assuring proper use (10).
We reported adjusted estimates from two out of three cluster
RCTs, because one RCT (35) might have unreliable results due
to low usage of face masks in participants: indeed, a low usage
of masks was reported in the face mask group, with adherence of
only 25% among participants. In contrast, a moderate proportion
of participants in the control group (49%) used face masks
daily and intermittently. This undermines the reliability of
results. We performed sensitivity analysis in order to present
routine situations in the community but the included three
places (schools, universities and in the general community)
have different characteristics (e.g., open/closed space, potential
confounder/interaction variable).
We did not appraise the quality of laboratory experimental
studies since we did not find appropriate tools for measuring
it. Similarly, for mathematical models we used the unfeasibility
appraisal, a proxy of quality assessment, which is more
appropriate given the nature of the studies. As for the
quantitative-deterministic studies, we acknowledge that such
models, especially when SIR-based, do not provide estimates
of events, but rather describe what could happen in the future
with respect to a predefined set of initial conditions. Namely,
they help stakeholders in understanding how the situation could
evolve in the future if different actions are adopted today. It
follows that pitfalls of such models can be due to mis-specified
initial conditions.
With new publications on COVID-19 related prediction
models rapidly entering the medical literature, this systematic
review cannot be viewed as an up to date list of all currently
available prediction models. Furthermore, there were some
studies among the ones we have reviewed that were available only
as preprints; such studies might actually bring new insights after
the peer-reviewing process.
Challenges and Opportunities for Public
Health
The speed of the worldwide spread of the SAR-COV-2
virus, leading to a severe pandemic for which there is no
effective treatment or vaccine and limited knowledge on disease
behavior, and the uncertainty regarding the role of asymptomatic
individuals in the transmission of the virus, call for Public Health
infection prevention and control measures, even in the absence
of evidence or in the presence of low quality scientific evidence.
A recent systematic review found that, in this pandemic, the
proportion of asymptomatic cases ranged from 4 to 41% (69).
In this light, universal masking in the community may mitigate
the extent of transmission of COVID-19 and may be a necessary
adjunctive public health measure (70).
The evidence-based medicine should be used with acumen.
The evidence-based GRADE approach suggest that whenever the
evidence in favor to the intervention is low but the risks related to
the averted implementation could be high, drastic measures can
be adopted even in the absence of solid evidence, if the conditions
are met (71).
The SARS-COV-2 pandemic is a life-threatening condition to
such an extent as to indicate the need of accepting a minimal
risk, assuming there is such a risk (i.e., mask costs), of the
community intervention (i.e., face mask use), considering the
notable benefit of its implementation, even if the evidence-base
is of low quality. Deferring these measures, on the other hand,
can have a negative effect on health policy decisions. This is
called “precautionary principle”: “when human activities may
lead to morally unacceptable harm that is scientifically plausible
but uncertain, actions shall be taken to avoid or diminish that
harm” (72, 73). The evidence, albeit imperfect, in support of the
use of masks in this context are justifiable and sufficient in light
of this principle. Although evidence-basedmedicine rightly looks
suspiciously at tests of low methodological quality, at the same
time it does not completely dismiss them, when circumstances
are appropriate, as in this case (8).
And, when it comes to parachuting from a plane that
is crashing, you wear it even if no trial has ever shown
its effectiveness compared to a control group that launched
without (74).
It should be emphasized that the use of face masks in the
community should be considered only as a complementary
measure and not as a replacement for the core preventive
measures that are recommended to reduce community
transmission including physical distancing, staying home
when ill, teleworking/home working if possible, respiratory
etiquette, meticulous hand hygiene and avoiding touching the
face, nose, eyes, and mouth (10). In conclusion, the use of
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face masks as single intervention is not sufficient to stop the
spread of COVID19 and a full package of the above mentioned
interventions is the safest and the most recommended approach.
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